Citations (109)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Søren Møller & Flemming Bendtsen. (2015) Complications of cirrhosis. A 50 years flashback. Scandinavian Journal of Gastroenterology 50:6, pages 763-780.
Read now
Read now
Deniz Yilmaz, Bülent Karapinar, Can Balkan, Mete Akisü & Kaan Kavakli. (2008) SINGLE-CENTER EXPERIENCE: Use of Recombinant Factor VIIa for Acute Life-Threatening Bleeding in Children without Congenital Hemorrhagic Disorder. Pediatric Hematology and Oncology 25:4, pages 301-311.
Read now
Read now
Thomas G DeLoughery. (2006) Management of bleeding emergencies: when to use recombinant activated Factor VII. Expert Opinion on Pharmacotherapy 7:1, pages 25-34.
Read now
Read now
Stephen J Wilson, Mark C Bellamy & Peter V Giannoudis. (2005) The safety and efficacy of the administration of recombinant activated factor VII in major surgery and trauma patients. Expert Opinion on Drug Safety 4:3, pages 557-570.
Read now
Read now
Alessandra Dell'Era & Jaime Bosch. (2005) Treatment of variceal bleeding in patients with cirrhosis of the liver. Clinical Intensive Care 16:3-4, pages 111-119.
Read now
Read now
M. Terblanche, M. Carrington & S.J. Brett. (2005) Is recombinant activated factor seven effective for haematemesis in patients with cirrhotic liver disease?. Clinical Intensive Care 16:3-4, pages 187-190.
Read now
Read now
Peter Kubisz & Ján Staško. (2004) Recombinant Activated Factor VII in Patients at High Risk of Bleeding. Hematology 9:5-6, pages 317-332.
Read now
Read now
Articles from other publishers (102)
Rajiv K. Pruthi & Dong Chen. (2023) The Use of Bypassing Treatment Strategies in Hemophilia and Their Effect on Laboratory Testing. Seminars in Thrombosis and Hemostasis 49:06, pages 651-660.
Crossref
Crossref
Bellal Joseph & Omar Obaid. 2022. Surgical Critical Care and Emergency Surgery. Surgical Critical Care and Emergency Surgery
181
188
.
Elizabeth A. Belloli & Steven E. Gay. 2020. Evidence-Based Critical Care. Evidence-Based Critical Care
511
517
.
Ping Lei, Guan-Xin Shen, Fu-Sheng Wang, Qin Ning, Hong Ren, Wei-Ming Yan & Di Wu. 2019. Acute Exacerbation of Chronic Hepatitis B. Acute Exacerbation of Chronic Hepatitis B
223
314
.
Kia Saeian, Akshay Kohli & Joseph Ahn. 2018. Hepatic Critical Care. Hepatic Critical Care
121
136
.
Avery L. Smith & Sumeet K. Asrani. (2017) Periprocedural management of acute variceal bleeding. Techniques in Gastrointestinal Endoscopy 19:2, pages 69-73.
Crossref
Crossref
Gilberto Silva-Junior, Anna Baiges, Fanny Turon, Virginia Hernandez-Gea & Juan Carlos Garcia-Pagan. (2017) Nonendoscopic management of acute esophageal variceal bleeding. Techniques in Gastrointestinal Endoscopy 19:2, pages 79-83.
Crossref
Crossref
Elizabeth A. Belloli & Steven E. Gay. 2017. Evidence-Based Critical Care. Evidence-Based Critical Care
535
544
.
Susan G. Hackner & Alexandre Rousseau. 2015. Small Animal Critical Care Medicine. Small Animal Critical Care Medicine
554
567
.
Sumit Kumar, Sumeet K. Asrani & Patrick S. Kamath. (2014) Epidemiology, Diagnosis and Early Patient Management of Esophagogastric Hemorrhage. Gastroenterology Clinics of North America 43:4, pages 765-782.
Crossref
Crossref
Margaret S. Sozio & Naga Chalasani. (2014) Activated recombinant factor VIIa should not be used in patients with refractory variceal bleeding: It is mostly ineffective, is expensive, and may rarely cause serious adverse events. Hepatology 60:5, pages 1786-1788.
Crossref
Crossref
Flemming Bendtsen, Gennaro D’Amico, Ea Rusch, Roberto de Franchis, Per Kragh Andersen, Didier Lebrec, Dominique Thabut & Jaime Bosch. (2014) Effect of recombinant Factor VIIa on outcome of acute variceal bleeding: An individual patient based meta-analysis of two controlled trials. Journal of Hepatology 61:2, pages 252-259.
Crossref
Crossref
Yi-Heng So, Huan-Tsung Chang, Wei-Jane Chiu & Chih-Ching Huang. (2014) Graphene oxide modified with aptamer-conjugated gold nanoparticles and heparin: a potent targeted anticoagulant. Biomater. Sci. 2:10, pages 1332-1337.
Crossref
Crossref
J. Bardon, J. Fink, J. de Montblanc, J.-F. Bergmann, B. Sarrut & D. Benhamou. (2013) Utilisation hors AMM du facteur VII activé recombinant (Novoseven®) à l’AP–HP en 2010. Annales Françaises d'Anesthésie et de Réanimation 32:10, pages 659-664.
Crossref
Crossref
R.M. Narváez-Rivera, C.A. Cortez-Hernández, J.A. González-González, J.L. Tamayo-de la Cuesta, F. Zamarripa-Dorsey, A. Torre-Delgadillo, J.F.J. Rivera-Ramos, J.I. Vinageras-Barroso, J.E. Muneta-Kishigami, J.M. Blancas-Valencia, M. Antonio-Manrique, F. Valdovinos-Andraca, P. Brito-Lugo, A. Hernández-Guerrero, R. Bernal-Reyes, S. Sobrino-Cossío, G.R. Aceves-Tavares, H.M. Huerta-Guerrero, N. Moreno-Gómez & F.J. Bosques-Padilla. (2013) Consenso Mexicano de Hipertensión Portal. Revista de Gastroenterología de México 78:2, pages 92-113.
Crossref
Crossref
Arturo J Martí-Carvajal, Despoina-Elvira Karakitsiou & Georgia Salanti. (2012) Human recombinant activated factor VII for upper gastrointestinal bleeding in patients with liver diseases. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Louis Voigt, Stephen M. Pastores & Neil A. Halpern. 2012. Blumgart's Surgery of the Liver, Pancreas and Biliary Tract. Blumgart's Surgery of the Liver, Pancreas and Biliary Tract
385
390.e3
.
E. K. Teo & K. M. Fock. (2011) Optimising the care of patients with cirrhosis and gastrointestinal haemorrhage. Alimentary Pharmacology & Therapeutics 34:5, pages 576-577.
Crossref
Crossref
Yen‐Chun Shiang, Chia‐Lun Hsu, Chih‐Ching Huang & Huan‐Tsung Chang. (2011) Gold Nanoparticles Presenting Hybridized Self‐Assembled Aptamers That Exhibit Enhanced Inhibition of Thrombin. Angewandte Chemie International Edition 50:33, pages 7660-7665.
Crossref
Crossref
Yen‐Chun Shiang, Chia‐Lun Hsu, Chih‐Ching Huang & Huan‐Tsung Chang. (2011) Gold Nanoparticles Presenting Hybridized Self‐Assembled Aptamers That Exhibit Enhanced Inhibition of Thrombin. Angewandte Chemie 123:33, pages 7802-7807.
Crossref
Crossref
Dennis M. Jensen, Thomas O. G. Kovacs & Disaya Chavalitdhamrong. 2011. Gastrointestinal Bleeding. Gastrointestinal Bleeding
97
118
.
Juan G. Abraldes, Jaime Bosch & Juan Carlos García-Pagan. 2011. Chronic Liver Failure. Chronic Liver Failure
477
500
.
Marco Senzolo & Andrew Kenneth Burroughs. 2011. Chronic Liver Failure. Chronic Liver Failure
453
476
.
Yen‐Chun Shiang, Chih‐Ching Huang, Tze‐Hsiang Wang, Chun‐Wei Chien & Huan‐Tsung Chang. (2010) Aptamer‐Conjugated Nanoparticles Efficiently Control the Activity of Thrombin. Advanced Functional Materials 20:18, pages 3175-3182.
Crossref
Crossref
Ampaiwan Chuansumrit, Sumate Teeraratkul, Suthep Wanichkul, Suporn Treepongkaruna, Nongnuch Sirachainan, Samart Pakakasama, Pracha Nuntnarumit & Suradej Hongeng. (2010) Recombinant-activated factor VII for control and prevention of hemorrhage in nonhemophilic pediatric patients. Blood Coagulation & Fibrinolysis 21:4, pages 354-362.
Crossref
Crossref
Oliver Flower, Louise E Phillips, Peter Cameron, Kerry Gunn, Scott Dunkley, Andrew Watts & Dorrilyn Rajbhandari. (2010) Recombinant activated factor VII in liver patients: a retrospective cohort study from Australia and New Zealand. Blood Coagulation & Fibrinolysis 21:3, pages 207-215.
Crossref
Crossref
Salvador Augustin. (2010) Acute esophageal variceal bleeding: Current strategies and new perspectives. World Journal of Hepatology 2:7, pages 261.
Crossref
Crossref
Thomas J. Savides & Dennis M. Jensen. 2010. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Sleisenger and Fordtran's Gastrointestinal and Liver Disease
285
322.e8
.
Richard P. Dutton, Maureen McCunn & Thomas E. Grissom. 2010. Miller's Anesthesia. Miller's Anesthesia
2277
2311
.
Pierpaolo Di Micco, Rosanna Di Fiore, Alferio Niglio, Sandro Quaranta, Antonella Angiolillo, Giuseppe Cardillo & Giuseppe Castaldo. (2008) Different outcome of six homozygotes for prothrombin A20210A gene variant. Journal of Translational Medicine 6:1.
Crossref
Crossref
Massimo Franchini, Martina Montagnana, Giovanni Targher, Marco Zaffanello & Giuseppe Lippi. (2008) The use of recombinant factor VIIa in liver diseases. Blood Coagulation & Fibrinolysis 19:5, pages 341-348.
Crossref
Crossref
Sharad Sharma, Ahmet Gurakar & Nicolas Jabbour. (2007) Avoiding Pitfalls: What an Endoscopist Should Know in Liver Transplantation—Part 1. Digestive Diseases and Sciences 53:7, pages 1757-1773.
Crossref
Crossref
F. Bendtsen, A. Krag & S. Møller. (2008) Treatment of acute variceal bleeding. Digestive and Liver Disease 40:5, pages 328-336.
Crossref
Crossref
Kadiyala V. Ravindra, Mary Eng & Michael Marvin. (2008) Current Management of Sinusoidal Portal Hypertension. The American Surgeon 74:1, pages 4-10.
Crossref
Crossref
Thomas Klitgaard & Tina G. Nielsen. (2007) Overview of the human pharmacokinetics of recombinant activated factor VII. British Journal of Clinical Pharmacology 65:1, pages 3-11.
Crossref
Crossref
Jaime Bosch, Annalisa Berzigotti, Juan Carlos Garcia-Pagan & Juan G. Abraldes. (2008) The management of portal hypertension: Rational basis, available treatments and future options. Journal of Hepatology 48, pages S68-S92.
Crossref
Crossref
Juan G. Abraldes & Jaime Bosch. (2007) The Treatment of Acute Variceal Bleeding. Journal of Clinical Gastroenterology 41:Supplement 3, pages S312-S317.
Crossref
Crossref
F. Pugliese, F. Ruberto, D. Summonti, S. Perrella, A. Cappannoli, A. Tosi, A. D’alio, K. Bruno, S. Martelli, P. Celli, V. Morabito, M. Rossi, P.B. Berloco & P. Pietropaoli. (2007) Activated Recombinant Factor VII in Orthotopic Liver Transplantation. Transplantation Proceedings 39:6, pages 1883-1885.
Crossref
Crossref
Jaime Bosch, Juan G. Abraldes & Juan Carlos García‐Pagán. 2007. Textbook of Hepatology. Textbook of Hepatology
640
657
.
Richard A. Weisiger, Maria T. DeSancho, Stephen M. Pastores & Rebecca G. Wells. 2007. Textbook of Hepatology. Textbook of Hepatology
250
273
.
Stephen H. Caldwell, Patrick G. Northup & Vinay Sundaram. 2007. Textbook of Hepatology. Textbook of Hepatology
1780
1797
.
Eva Girona, Joaquín Borrás-Blasco, Venancio Conesa-García, Andrés Navarro-Ruiz, Javier Solís, Mariana Fe García-Sepulcre & Israel Oliver-García. (2007) Successful Treatment of Severe Gastrointestinal Bleeding Secondary to Crohn Disease with Recombinant Factor VIIa. Southern Medical Journal 100:6, pages 601-604.
Crossref
Crossref
E. Tsochatzis, G.V. Papatheodoridis, I. Elefsiniotis, S. Thanelas, G. Theodossiades, A. Moulakakis & A.J. Archimandritis. (2007) Prophylactic and therapeutic use of recombinant activated factor VII in patients with cirrhosis and coagulation impairment. Digestive and Liver Disease 39:5, pages 490-494.
Crossref
Crossref
A. González Castro, B. Suberviola Cañas, E. Miñambres & F. Ortiz Melón. (2007) Factor VIIa recombinante (rFVIIa). Descripción de uso en una cohorte de enfermos críticos y marcadores pronósticos. Medicina Intensiva 31:5, pages 215-219.
Crossref
Crossref
Neeraj Agarwal, Joseph E Spahr & George M Rodgers. (2007) Successful management of intra-abdominal hemorrhage in the presence of severe alcoholic liver disease with activated recombinant factor VII (rFVIIa; NovoSeven): a case report and review of the literature on approved and off-label use of rFVIIa. Blood Coagulation & Fibrinolysis 18:2, pages 205-207.
Crossref
Crossref
Arturo J Martí-Carvajal, Georgia Salanti & Pedro I. Marti-Carvajal. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
K. Engelhardt, C. Brenneis, B. Pfausler, R. Beer, G. Brössner, R. Helbok, P. Lackner & E. Schmutzhard. (2007)
rFVII
a
– for acute rebleeding of a cerebral cavernous malformation
. European Journal of Neurology 14:1, pages 117-120.
Crossref
Crossref
Marco Senzolo & Andrew K. Burroughs. 2007. Consultative Hemostasis and Thrombosis. Consultative Hemostasis and Thrombosis
647
659
.
D.N. SAMONAKIS, C.K. TRIANTOS, J. GOULIS & A.K. BURROUGHS. 2007. Surgery of the Liver, Biliary Tract and Pancreas. Surgery of the Liver, Biliary Tract and Pancreas
1563
1578
.
L. VOIGT, S.H. SIGAL & N.A. HALPERN. 2007. Surgery of the Liver, Biliary Tract and Pancreas. Surgery of the Liver, Biliary Tract and Pancreas
397
403
.
Barbara Alving. 2007. Blood Banking and Transfusion Medicine. Blood Banking and Transfusion Medicine
482
495
.
MARIE E. STEINER & NIGEL S. KEY. (2006) Use of recombinant activated factor VII in the management of medical and surgical bleeding: a critical review. Transfusion Alternatives in Transfusion Medicine 8:s1, pages 66-80.
Crossref
Crossref
James F. Trotter. (2006) Coagulation Abnormalities in Patients Who Have Liver Disease. Clinics in Liver Disease 10:3, pages 665-678.
Crossref
Crossref
Nazia Selzner, Janet E. Tuttle‐Newhall & Beat Müllhaupt. 2006. Medical Care of the Liver Transplant Patient. Medical Care of the Liver Transplant Patient
43
65
.
C. U. Niemann, M. Behrends, D. Quan, H. Eilers, M. A. Gropper, J. P. Roberts & R. Hirose. (2006) Recombinant factor VIIa reduces transfusion requirements in liver transplant patients with high MELD scores. Transfusion Medicine 16:2, pages 93-100.
Crossref
Crossref
J. da Silva Viana. (2006) Recombinant Factor VIIa in Major Abdominal Surgery and Liver Transplantation. Transplantation Proceedings 38:3, pages 818-819.
Crossref
Crossref
M Senzolo. (2006) New insights into the coagulopathy of liver disease and liver transplantation. World Journal of Gastroenterology 12:48, pages 7725.
Crossref
Crossref
R. Michael Grounds, Caroline Seebach, Christoph Knothe, Piotr Paluszkiewicz, Terry S. Smith, Eduard Kasal, Ramon Lecumberri, Rene Urbanec, Thorsten Haas, Maria Wujtewicz, Dagmar Rehorkova, Martina Pelichovska, Martina Lange, Maite Uranga, Roman Bosman, J. Hans Rommes & Juergen Koscielny. (2016) Use of Recombinant Activated Factor VII (Novoseven) in Trauma and Surgery: Analysis of Outcomes Reported to an International Registry. Journal of Intensive Care Medicine 21:1, pages 27-39.
Crossref
Crossref
Young Woon Chang. (2005) INDICATION OF TREATMENT FOR ESOPHAGEAL VARICES: WHO AND WHEN?. Digestive Endoscopy 18:1, pages 10-15.
Crossref
Crossref
Hendrik Vilstrup, Malgorzata Markiewicz, Douwe Biesma, Vesna Vegar Brozovic, Nikolay Laminoga, Marcin Malik, Stoyan Milanov, David Patch & Vilian Platikanov. (2006) Recombinant activated factor VII in an unselected series of cases with upper gastrointestinal bleeding. Thrombosis Research 118:5, pages 595-601.
Crossref
Crossref
Loren Laine, Ramón Planas, Frederik Nevens, Rafael Bañares, David Patch & Jaime Bosch. 2006. Portal Hypertension IV. Portal Hypertension IV
217
242
.
I. J. Welsby, D. M. Monroe, J. H. Lawson & M. Hoffmann. (2005) Recombinant activated factor VII and the anaesthetist. Anaesthesia 60:12, pages 1203-1212.
Crossref
Crossref
Juan G. Abraldes, Bernhard Angermayr & Jaime Bosch. (2005) The Management of Portal Hypertension. Clinics in Liver Disease 9:4, pages 685-713.
Crossref
Crossref
Robert MacLaren, Laura A. Weber, Helga Brake, Melinda A. Gardner & Mario Tanzi. (2005) A multicenter assessment of recombinant factor VIIa off‐label usage: clinical experiences and associated outcomes. Transfusion 45:9, pages 1434-1442.
Crossref
Crossref
Yüksel Pekçelen, Akif S Yavuz, Sule Namli & Ahmet Gücükoglu. (2005) Short-course use of recombinant factor VIIa in a haemophilia patient with inhibitor undergoing cataract surgeries. Blood Coagulation & Fibrinolysis 16:6, pages 445-446.
Crossref
Crossref
Andrew S. Wright & Layton F. Rikkers. (2005) Current Management of Portal Hypertension. Journal of Gastrointestinal Surgery 9:7, pages 992-1005.
Crossref
Crossref
M. Jiménez-Sáenz & R. Romero-Castro. (2005) El factor VII recombinante en el tratamiento de la hemorragia aguda por varices esofágicas. Gastroenterología y Hepatología 28:6, pages 333-336.
Crossref
Crossref
Ante Tonkic, Ivana Jukic, Marina Titlic & Stjepan Mise. (2005) Successful treatment of massive acute upper gastrointestinal bleeding in liver failure with activated recombinant factor VII (NovoSeven): a case report. Blood Coagulation & Fibrinolysis 16:5, pages 385-387.
Crossref
Crossref
Jody L. Kujovich. (2005) Hemostatic Defects in End Stage Liver Disease. Critical Care Clinics 21:3, pages 563-587.
Crossref
Crossref
DAVID H VAN THIEL, DEBORAH E FARR, AYSE L MINDIKOGLU, AKIRA TODO & MAGDALENE M GEORGE. (2005) Recombinant human factor VIIa‐induced alterations in tissue factor and thrombomodulin in patients with advanced liver cirrhosis. Journal of Gastroenterology and Hepatology 20:6, pages 882-889.
Crossref
Crossref
Marcel Levi, Marjolein Peters & Harry R. Büller. (2005) Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: A systematic review. Critical Care Medicine 33:4, pages 883-890.
Crossref
Crossref
Manuel Jimenez-saenz. (2005) Recombinant Factor VIIa for Variceal Bleeding: When, Why, and How?. Gastroenterology 128:4, pages 1150-1151.
Crossref
Crossref
Mark W Russo. (2005) FACTOR VIIA FOR UPPER GI BLEEDING IN CIRRHOTIC PATIENTS: IT IS ALL IN THE STUDY DESIGN. Evidence-Based Gastroenterology 6:1, pages 22-23.
Crossref
Crossref
Roberto de Franchis. 2005. Portal Hypertension. Portal Hypertension
183
198
.
Harold R. RobertsDougald M. MonroeGilbert C. White. (2004) The use of recombinant factor VIIa in the treatment of bleeding disorders. Blood 104:13, pages 3858-3864.
Crossref
Crossref
R. de Franchis, A. Dell’Era & F. Iannuzzi. (2004) Diagnosis and treatment of portal hypertension. Digestive and Liver Disease 36:12, pages 787-798.
Crossref
Crossref
D N Samonakis, C K Triantos, U Thalheimer, D W Patch & A K Burroughs. (2004) Management of portal hypertension. Postgraduate Medical Journal 80:949, pages 634-641.
Crossref
Crossref
Michael G Aitken. (2009) Recombinant factor VIIa. Emergency Medicine 16:5-6, pages 446-455.
Crossref
Crossref
Jaime Bosch, Dominique Thabut, Flemming Bendtsen, Gennaro D’Amico, Agustín Albillos, Juan González Abraldes, Soeren Fabricius, Elisabeth Erhardtsen & Roberto de Franchis. (2004) Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: A randomized, double-blind trial. Gastroenterology 127:4, pages 1123-1130.
Crossref
Crossref
A. Dell'era & J. Bosch. (2004) The relevance of portal pressure and other risk factors in acute gastro‐oesophageal variceal bleeding. Alimentary Pharmacology & Therapeutics 20:s3, pages 8-15.
Crossref
Crossref
Guy Young. (2008) Novel Hemostatic Agents: A Focus on Recombinant Factor VIIa and Factor XIII. Transfusion Alternatives in Transfusion Medicine 6:2, pages 37-45.
Crossref
Crossref
Erik J Uhlmann & Charles S Eby. (2004) Recombinant activated factor VII for non-hemophiliac bleeding patients. Current Opinion in Hematology 11:3, pages 198-204.
Crossref
Crossref
Dominique Pateron. (2004) Évaluation et prise en charge non spécifique. Gastroentérologie Clinique et Biologique 28, pages 179-185.
Crossref
Crossref
Aurélie Plessier. (2004) Comment traiter une hémorragie digestive aiguë par rupture de varices oesophagiennes. Gastroentérologie Clinique et Biologique 28, pages 9-14.
Crossref
Crossref
W. Sapsford. (2016) The Potential Use of Recombinant Activated Factor VII in Trauma and Surgery. Scandinavian Journal of Surgery 93:1, pages 17-23.
Crossref
Crossref
Stephen H. Caldwell, Charissa Chang & B. Gail Macik. (2004) Recombinant activated factor VII (rFVIIa) as a hemostatic agent in liver disease: A break from convention in need of controlled trials. Hepatology 39:3, pages 592-598.
Crossref
Crossref
Madhu V. Midathada, Paulette Mehta, Milton Waner & Louis M. Fink. (2004) Recombinant Factor VIIa in the Treatment of Bleeding. American Journal of Clinical Pathology 121:1, pages 124-137.
Crossref
Crossref
Yves Ozier & Aline Albi. (2004) Liver Transplant Surgery and Transfusion. International Anesthesiology Clinics 42:3, pages 147-162.
Crossref
Crossref
Michael A Silva, Vijayaragavan Muralidharan & Darius F Mirza. (2004) The management of coagulopathy and blood loss in liver surgery. Seminars in Hematology 41, pages 132-139.
Crossref
Crossref
Jaime Bosch & Juan G Abraldes. (2004) Management of gastrointestinal bleeding in patients with cirrhosis of the liver. Seminars in Hematology 41, pages 8-12.
Crossref
Crossref
Roberto De Franchis. 2004. Portal Hypertension in the 21st Century. Portal Hypertension in the 21st Century
241
249
.
Gregory J. Monkewich & Norman E. Marcon. 2004. Portal Hypertension in the 21st Century. Portal Hypertension in the 21st Century
185
207
.
Angels Escorsell & Jaime Bosch. 2004. Portal Hypertension in the 21st Century. Portal Hypertension in the 21st Century
155
166
.
Rekha Parameswaran & Amy D. Shapiro. (2008) The Use of Recombinant Factor VIIa in Gastrointestinal Bleeding. Transfusion Alternatives in Transfusion Medicine 5:s5, pages 23-30.
Crossref
Crossref
Raúl Tonda, Ana Marı́a Galán, Marcos Pino, Isabel Cirera, Jaume Bosch, Marı́a Rosa Hernández, Antonio Ordinas & Ginés Escolar. (2003) Hemostatic effect of activated recombinant factor VII (rFVIIa) in liver disease: studies in an in vitro model. Journal of Hepatology 39:6, pages 954-959.
Crossref
Crossref
Mike Grounds. (2003) Recombinant factor VIIa (rFVIIa) and its use in severe bleeding in surgery and trauma: a review. Blood Reviews 17, pages S11-S21.
Crossref
Crossref
Margarita Pardo, Javier Sánchez, Francisco J. Quemada, Alfonso Del Corral, Javier Bartolomé & Vicente Carreño. (2003) To the Editor. World Journal of Surgery 27:6, pages 758-759.
Crossref
Crossref
Jaime Bosch, Juan G Abraldes & Roberto Groszmann. (2003) Current management of portal hypertension. Journal of Hepatology 38, pages 54-68.
Crossref
Crossref
JUAN G ABRALDES & JAIME BOSCH. (2008) Novel approaches to treat portal hypertension. Journal of Gastroenterology and Hepatology 17:s3.
Crossref
Crossref
Ton Lisman, Frank W.G. Leebeek & Philip G. de Groot. (2002) Haemostatic abnormalities in patients with liver disease. Journal of Hepatology 37:2, pages 280-287.
Crossref
Crossref
W Sapsford. (2016) A role for recombinant activated factor VII in trauma?. Trauma 4:2, pages 117-123.
Crossref
Crossref
Ton Lisman, Frank W.G. Leebeek, Karina Meijer, Jan Van Der Meer, H. Karel Nieuwenhuis & Philip G. De Groot. (2002) Recombinant factor VIIa improves clot formation but not fibrolytic potential in patients with cirrhosis and during liver transplantation. Hepatology 35:3, pages 616-621.
Crossref
Crossref